期刊文献+

不同类型颈动脉斑块与血清高敏C反应蛋白水平相关性研究 被引量:2

Correlation study of different types of carotid artery plaque and hs-CRP level
原文传递
导出
摘要 目的:研究不同类型颈动脉斑块与血清中高敏C反应蛋白水平的相关性。方法:收集我院住院病人60例,分别检查每位患者左右侧颈总动脉、颈内动脉及颈外动脉,观察斑块大小、形态及性质,检测每位患者血清中高敏C反应蛋白的浓度,并与50例正常者进行对照分析,研究总结二者之间的相关性。结果:不同类型颈动脉斑块患者血清中高敏C反应蛋白的浓度不同,软斑组较硬斑组高,但均较正常对照组高,差异有统计学意义;混合斑块组升高程度介于软斑与硬斑组之间。结论:颈动脉斑块患者血清中高敏C反应蛋白的浓度较正常人高,不同类型斑块患者血清高敏C反应蛋白浓度也有差异,可以作为临床防治急性事件的诊断依据之一。 Objective: To study the dependencies on different type of carotid artery plaque and serum C-reactive protein levels in patients. Methods: Sixty cases of inpatients were collected in our hospital, each patient's common carotid artery, internal carotid artery and the external carotid artery were checked, the size of plaque, and its shape, nature were observed, each patient's serum high-sensitivity c-reactive protein concentrations were tested, then the correlations with 50 healthy peoples were analysised. Results: Different type of carotid artery plaque in patients had different serum high-sensitivity C-reactive protein levels. It was higher in soft spot group than that in hard spot group, but those in the two groups were all higher than that in the normal group, there were significant statistical differences. The mixed plaques group had a high degree between the groups of soft spots and hard spots. Conclusion: The Serum high-sensitivity C-reactive protein in patients with carotid artery plaques were higher than that in normal group, there were significant differences of the serum C- reactive protein levels in patients with different types of plaques, which could be used as one of the clinical diagnosis of an acute event.
出处 《现代医学》 2014年第3期294-296,共3页 Modern Medical Journal
关键词 颈动脉斑块 高敏 C反应蛋白 carotid artery plaque high- sensitivity C- reactive protein
  • 相关文献

参考文献11

二级参考文献18

  • 1王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1421
  • 2任成山.对多器官功能衰竭概念和诊断标准的新认识[J].中国危重病急救医学,1995,7(6):344-345. 被引量:37
  • 3高晓兰 胡长梅 等.脑卒中临床数据库资料对比分析[J].中华神经科杂志,1999,32:160-160.
  • 4Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor[J]. Stroke, 2001, 32: 917.
  • 5Tohgi H, Takahashi H, Tamura K, et, al. Ischemic stroke among in patients with preceding inflammatory response[J]. Thromb Res, 2001, 104: 375.
  • 6Iyigun I, Bakirci Y. Plasma concentrations of C-reactive protein and fibrinog in ischemic stroke[J].J Int Med Res,2002,33:591.
  • 7Winbeck K, Poppert H, Etgen T, et, al. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke[J]. Stroke, 2003, 34: 375.
  • 8Iyigun I. C-reactive protein in ischemic stroke[J]. Stroke, 2002, 33: 2146.
  • 9Kawai T. Inflammatory markers, especially the mechanism of increased CRP[J].Rinsho Byori,2000, 48: 719
  • 10Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischemic stroke: an integrated view[J]. Trends Neurosci,1999, 22: 391

共引文献521

同被引文献20

  • 1Di SEIASEIO G, PATH G, PASCEFI V, et al. Efficacy of atorv- astatin reload in patients on chronic statin therapy undergoingpercutaneous coronary intervention: results of the ARMYDA- RECAPTURE(Atorvastatin for Reduction of Myocardial Damge During Angioplasty) Randomized Trial [ J ]. J Am Col Cardiol, 2009,54(6) :566-568.
  • 2ACAR Z, KALE A, TURGUT M, et al. Efficiency of atorvasta- tin in the protection of anthracycline-induced cardiomyopathy [J]. J Am Coil Cardiol,2011,58 :988-989.
  • 3LI D, PATEL A R, KUBANOV A L, et al. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor Lox-1 using SPECT/CT and magnetic resonance [ J ]. Cire Car- diovasc Imaging, 2010,3 (4) :464- 472.
  • 4IOANNIDIS J P A, KARVOUNI E, KATRITIS D G, et al. Mor- tality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous intervention[ J]. J Am Coil Car- dio1,2003,42 : 1406-1411.
  • 5PATI" G, PASCERI V, COLONNA G, et al. Atorvastatin pre- treatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary interven- tion : results of the ARMYDA- ACS randomized trial [ J ]. J Am Coil Cardiol.2007.49 ( 12 )1272-1278.
  • 6YUN K H,JEONG M H,OH S K,et al. Response of high-sen- sitivity C-reactive protein to percutaneous coronary interven- tion in patients with acute coronary syndrome [ J ]. Heart Ves- sels ,2009,24( 3 ) : 175-180.
  • 7TERESA N, SERENA D T, SERGIO B, et al. The Lectin- like oxidized low- density lipoprotein receptor- 1 and its soluble form: cardiovascular implications [ J ]. J Atheroscler Thromb, 2010,17:317-331.
  • 8SHIH H H, ZHANG S, CAO W, et al. CRP is a novel ligand for the oxidized LDL receptor LOX- 1 [ J ]. Am J Physiol Heart Cire Physiol, 2009,296 (5) : H 1643-1650.
  • 9HEIN T W, QAMIRANI E, REN Y, et al. Selective activation of lectin-like oxidized low-density lipoprotein receptor-1 me- diates C-reactive protein-evoked endothelial vasodilator dys- function in coronary arterioles[J]. Circ Res, 2014 ,114( I ) : 92-100.
  • 10CHEN X P,ZHANG T T,DU G H. Lectin-like oxidized low- density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? [ J ]. Cardiovasc Drug Rev, 2007, 25(2) :146-161.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部